RaST-treated CR mice showed a remarkable increase in the mean concentrations of negative regulators of the immune system, sLAG-3, and sPD-L1, compared to the naïve and untreated tumor-bearing mice (Fig. 6i). This evidence concerns the gene SPDL1 and neoplasm.